American Journal of Psychiatry
- Volume 181
- Number 3
- March 2024
Editor’s Note
Editorials
Review and Overview
Publication date: 01 March 2024
Pages189–200This overview critically appraises the literature on the treatment of pediatric anxiety disorders. The two established treatments for these conditions comprise cognitive-behavioral therapy (CBT) and antidepressant medications. Many youths receiving these ...
https://doi.org/10.1176/appi.ajp.20231037Articles
Publication date: 24 January 2024
Pages201–212Objective: Anxiety disorders are prevalent among youths and are often highly impairing. Cognitive-behavioral therapy (CBT) is an effective first-line treatment. The authors investigated the brain mechanisms associated with symptom change following CBT. ...
https://doi.org/10.1176/appi.ajp.20220449Publication date: 07 February 2024
Pages213–222Objective: The authors sought to determine whether the Fast Track mental health intervention delivered to individuals in childhood decreased mental health problems and the need for health services among the children of these individuals. Methods: The authors ...
https://doi.org/10.1176/appi.ajp.20220927Publication date: 07 February 2024
Pages223–233Objective: Response to antidepressant treatment in major depressive disorder varies substantially between individuals, which lengthens the process of finding effective treatment. The authors sought to determine whether a multimodal machine learning ...
https://doi.org/10.1176/appi.ajp.20230206Publication date: 07 February 2024
Pages234–245Objective: The authors evaluated whether treatment of late-life depression (LLD) with antidepressants leads to changes in cognitive function. Methods: A systematic review and meta-analysis of prospective studies of antidepressant pharmacotherapy for adults ...
https://doi.org/10.1176/appi.ajp.20230392Publication date: 20 September 2023
Pages246–254Objective: The authors investigated the frequency and determinants of long-term use and risk of dose escalation of benzodiazepines and benzodiazepine-related drugs (benzodiazepine receptor agonists, or BZRAs). Methods: All adults ages 20–80 years living in ...
https://doi.org/10.1176/appi.ajp.20230075Correction
Past Issues
View Issues Archive
Vol. 181 | No. 11
Vol. 181 | No. 10
Vol. 181 | No. 9
